In a mouse model of PD, curcumin administration over an extended period (2–5 months) reduced the neurotoxicity of MPTP by upregulating the levels of TGFβ1 (transforming growth factor beta 1) and GDNF (glial cell line-derived neurotrophic factor) [207,208]. The gene discussed is GDNF; the disease is Parkinson disease.